Can lisinopril (ACE inhibitor) be given together with metoprolol (beta‑blocker)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Lisinopril and Metoprolol Be Given Together?

Yes, lisinopril (ACE inhibitor) and metoprolol (beta-blocker) can and should be given together when clinically indicated—this is a well-established, guideline-supported combination for multiple cardiovascular conditions.

Guideline Support for Combination Therapy

The 2024 ESC Guidelines explicitly recommend beta-blockers be combined with other major blood pressure-lowering drug classes (including ACE inhibitors) when there are compelling indications such as angina, post-myocardial infarction, heart failure with reduced ejection fraction, or heart rate control 1. This represents a Class I, Level A recommendation—the highest level of evidence 1.

For hypertension management specifically, the preferred initial combinations are a RAS blocker (ACE inhibitor or ARB) with either a calcium channel blocker or diuretic 1. However, beta-blockers are appropriately added when additional indications exist beyond blood pressure control alone 1.

Clinical Evidence Supporting the Combination

Blood Pressure Control

  • Multiple studies demonstrate that combining lisinopril with beta-blockers produces additive blood pressure reduction 2, 3
  • In patients inadequately controlled on atenolol alone, adding lisinopril 10-20 mg produced additional reductions of 7.1/5.4 mmHg lying and 7.6/4.7 mmHg standing blood pressure 3
  • The combination is as effective as traditional beta-blocker plus diuretic therapy 2

Complementary Mechanisms

The combination provides complementary cardiovascular protection by targeting two interlinked pathways: the sympathetic nervous system (beta-blockers) and the renin-angiotensin-aldosterone system (ACE inhibitors) 4. This dual mechanism addresses multiple aspects of cardiovascular risk across the disease continuum 4.

Safety Considerations and Monitoring

Primary Concern: Hypotension

The main risk when combining these agents is excessive blood pressure reduction 5. To minimize this risk:

  • Monitor blood pressure closely after initiating combination therapy 5
  • Consider reducing or temporarily discontinuing diuretics before starting lisinopril if the patient is already on beta-blocker therapy 5
  • If diuretic discontinuation isn't possible, reduce the starting dose of lisinopril 5
  • Watch for symptomatic orthostatic hypotension, particularly in volume or salt-depleted patients 5

Additional Monitoring Parameters

  • Serum potassium: ACE inhibitors can increase potassium levels (mean increase ~0.1 mEq/L), though this is generally modest 5
  • Renal function: Monitor periodically, especially if NSAIDs are co-administered 5
  • Heart rate: Beta-blockers will reduce heart rate; ensure it doesn't become excessively bradycardic 2

Important Drug Interaction Note

A recent case report documented profound hypotension when tizanidine (a muscle relaxant) was given with lisinopril and metoprolol 6. While this involved a third agent, it underscores the importance of reviewing all medications that can affect blood pressure when using this combination 6.

Contraindications to Lisinopril (Regardless of Beta-Blocker Use)

Do not use lisinopril in patients with 5:

  • History of angioedema or hypersensitivity to ACE inhibitors
  • Hereditary or idiopathic angioedema
  • Concurrent use with aliskiren in diabetic patients

Clinical Scenarios Where This Combination Is Particularly Appropriate

  • Post-myocardial infarction: Both agents have mortality benefits 1, 4
  • Heart failure with reduced ejection fraction: Both are cornerstone therapies 7, 4
  • Hypertension with angina: Beta-blockers treat angina while ACE inhibitors provide additional blood pressure control 1, 4
  • Hypertension requiring multiple agents: When blood pressure isn't controlled on monotherapy 1, 3

Practical Prescribing Approach

When combining these medications:

  1. Start with standard doses unless the patient has risk factors for hypotension (elderly, volume depleted, frail) 1
  2. Measure blood pressure 1 hour and 6 hours after the first combined dose if feasible, as lisinopril shows onset at 1 hour with peak effect at 6 hours 5
  3. Recheck blood pressure at 24 hours to assess trough effect 5
  4. Titrate to target doses over approximately 3 months to optimize cardiovascular protection while maintaining patient confidence and adherence 1
  5. Consider fixed-dose combination pills when available to improve adherence 1

Related Questions

What are the key factors to assess in a post-operative (post-op) cardiac patient?
Can a patient being worked up for chest pain continue taking Angiotensin-Converting Enzyme (ACE) inhibitors and beta blockers?
What medication increase would best decrease blood pressure in a 61-year-old female patient with a history of hypertension (HTN), currently managed with atenolol (beta blocker) 25 mg daily and hydrochlorothiazide (HCTZ) (thiazide diuretic) 25 mg daily, presenting with hypertension?
Can lisinopril (Angiotensin-Converting Enzyme (ACE) inhibitor) and bisoprolol (Beta (β) blocker) be taken together?
What is the diagnosis and management plan for a patient with a history of normal myocardial perfusion study, normal ejection fraction (EF) with mild left ventricular hypertrophy (LVH) and impaired relaxation filling pattern, mild aortic valve calcification, and moderate mitral valve calcification, presenting with shortness of breath, 1+ to 2+ pitting edema, and currently taking Furosemide (Lasix) 20 milligrams (mg) daily?
Should an electromyography (EMG) be obtained now to exclude amyotrophic lateral sclerosis (ALS) in this patient?
Should an electromyography (EMG) with nerve‑conduction studies be performed now for a patient with progressive focal weakness, fasciculations, and possible upper‑motor‑neuron signs?
Does Lexapro (escitalopram) cause overactive bladder symptoms?
Can you provide illustrated stretching exercises for patellofemoral pain syndrome?
What is the appropriate workup and management for a patient presenting with upper abdominal swelling?
Can pudendal neuralgia cause inner thigh pain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.